Atinumab

Description: Atinumab (6A3-IgG4) is a monoclonal antibody inhibitor targeting reticulon-4 (Nogo) that stimulates the growth of neural protrusions and has immunomodulatory activity. Target: Others. References: Kucher K, Johns D, Maier D, Abel R, Badke A, Baron H, Thietje R, Casha S, Meindl R, Gomez-Mancilla B, Pfister C, Rupp R, Weidner N, Mir A, Schwab ME, Curt A. First-in-Man Intrathecal Application of Neurite Growth-Promoting Anti-Nogo-A Antibodies in Acute Spinal Cord Injury. Neurorehabil Neural Repair. 2018 Jun,32(6-7):578-589.